Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...
Conference call to provide business updates today, February 25 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 25 ...
China NMPA accepts for priority review GSK’s NDA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Friday, February 27, 2026, 14: ...
In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.
Merck Animal Health announced today the FDA approved atinvicitinib tablets (NUMELVI; Merck Animal Health), making it the first and only second-generation Janus kinase (JAK) inhibitor indicated for ...
Drugmaker GSK said on Thursday that regulators in Japan and China had accepted two separate new drug applications for review, covering investigational treatments targeting chronic hepatitis B and ...
Rahway, New Jersey Friday, February 27, 2026, 10:00 Hrs [IST] ...
Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...
Can stopping washcloth use ease pruritus? A new study suggests a simple bathing change may reduce itch severity. Learn more about the findings.
Minimal disease activity in atopic dermatitis is sustainable at one year in early responders. Discover predictors and ...
MedPage Today on MSN
New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease
Difamilast demonstrated safety, efficacy in multiple eczema trials, joins crisaborole, rof ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results